The Genetic Analysis of Neurological Diseases. Multiple sclerosis and Parkinson's are debilitating neurodegenerative diseases, which affect 16,000 and 80,000 Australians, respectively. Between them, these diseases cost the community $7.8 billion per annum, and there is no cure. This proposal will study the genes that influence a person's predisposition to developing these diseases, and what makes some people have particular characteristics. It will provide novel insights into the diseases themse ....The Genetic Analysis of Neurological Diseases. Multiple sclerosis and Parkinson's are debilitating neurodegenerative diseases, which affect 16,000 and 80,000 Australians, respectively. Between them, these diseases cost the community $7.8 billion per annum, and there is no cure. This proposal will study the genes that influence a person's predisposition to developing these diseases, and what makes some people have particular characteristics. It will provide novel insights into the diseases themselves and information that could help in the development of new and more effective drugs, and biomarkers to assist in the prediction of prognosis. Such advances would decrease the economic impact of these diseases and improve quality of life for those affected.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0882219
Funder
Australian Research Council
Funding Amount
$100,000.00
Summary
Infrastructure for an integrated cognitive neurophysiological research facility: Mapping the neurobiology of memory and language. The Integrated Cognitive Neurophysiological Research Facility will enhance Australia's national research capacity in cognitive neuroscience by enabling large numbers of researchers and graduate students to investigate the neuroscience of memory and language in a collaborative, multi-disciplinary research environment. The facility will deliver national benefits by unco ....Infrastructure for an integrated cognitive neurophysiological research facility: Mapping the neurobiology of memory and language. The Integrated Cognitive Neurophysiological Research Facility will enhance Australia's national research capacity in cognitive neuroscience by enabling large numbers of researchers and graduate students to investigate the neuroscience of memory and language in a collaborative, multi-disciplinary research environment. The facility will deliver national benefits by uncovering the ways in which areas of the brain are used to remember events and process language. This information can then be used to understand how damage to the brain (such as in stroke or disease) can disrupt memory and language and subsequently lead to more effective neurorehabilitation techniques.Read moreRead less
Discovery Indigenous Researchers Development - Grant ID: DI0560757
Funder
Australian Research Council
Funding Amount
$160,896.00
Summary
Identification and Characterisation of Genes involved in the Copper Regulation of the Human Alzheimer's Disease Amyloid-Beta Precursor Protein (APP) Gene. Alzheimer's disease (AD) is the most common form of dementia in the ageing population. This research project aims to identify and characterise new genes involved in the copper regulation of the Alzheimer's disease gene. This may lead to the development of novel therapeutic targets and clinical intervention strategies as well as early diagnost ....Identification and Characterisation of Genes involved in the Copper Regulation of the Human Alzheimer's Disease Amyloid-Beta Precursor Protein (APP) Gene. Alzheimer's disease (AD) is the most common form of dementia in the ageing population. This research project aims to identify and characterise new genes involved in the copper regulation of the Alzheimer's disease gene. This may lead to the development of novel therapeutic targets and clinical intervention strategies as well as early diagnostic procedures in preventative healthcare for the treatment of AD. The benefits would affect the international community as a whole, potentially minimising the socio-economic costs arising from the predicted world-wide increase in AD in the ageing population.Read moreRead less